Track topics on Twitter Track topics that are important to you
Imugene’s goal is to improve the efficacy and safety of a diverse number of existing prescription and over the counter medicines both locally and globally. Each new drug formulation being developed by Imugene addresses an unmet market need and uses well characterised molecules that have known and proven regulatory routes.
Imugene aims to develop and license a Vitamin D formulation using its platform technology Linguet™. Generic pharmaceutical products focusing on Parkinson’s Disease and over-the-counter pain relief markets are planned for later in 2014.
Imugene’s focus is on pushing early revenue generating products, rather than a classic drug delivery model that focuses on a single opportunity licensing deal far into the future. We are targeting pharmaceutical products that do not need significant clinical investment to gain regulatory approval. This ensures the most cost effective and most rapid path to market.
Linguet is targeted at those drugs which:
While the Linguet™ technology has potentially broad applications, Imugene has selected four priority targets initially:
Suite 1, 1233 High Street
Phone: +61 3 9824 5254
Fax: +61 3 9822 7735
Edison Investment Research - Pharmaceutical & healthcare - Imugene: Imugene has in-licenced a pipeline of B-cell vaccines that complements and advances its in-house programme. The deal has brought for...
Imugene has concluded patient enrolment in a Phase lb clinical trial of its HER-Vaxx cancer vaccine IMU-131 for the treatment...Read More... The post Imugene completes enrolment in Phase lb trial of I...
SummaryImugene Ltd Imugene is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immuneoncology. The company focuses on developing immunotherapies for the...
Imugene’s goal is to improve the efficacy and safety of a diverse number of existing prescription and over the counter medicines both locally and globally. Each new drug formulation being deve...
We have published hundreds of Imugene news stories on BioPortfolio along with dozens of Imugene Clinical Trials and PubMed Articles about Imugene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Imugene Companies in our database. You can also find out about relevant Imugene Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...